With cell and gene therapies entering a scale-up phase and driving market growth, strategic collaborations and investments are accelerating. At ProBio, we see these therapies as a beacon of hope for patients and remain committed to supporting biopharma innovators with high-quality, responsive manufacturing solutions.

 

We’re proud to share a video tour of our flagship Cell and Gene Therapy Center of Excellence at Princeton West Innovation Campus in Hopewell, NJ. This 128,000 sq ft GMP facility is purpose-built for plasmid DNA and viral vector manufacturing, including AAV and LVV platforms, underscoring our dedication to advancing transformative medicines.